samedan logo
home > pmps > winter 2020 > thermoforming: the ideal product packaging solution?
Pharmaceutical Manufacturing and Packing Sourcer

Thermoforming: The Ideal Product Packaging Solution?

Pharmaceutical and medical manufacturers are under increasing pressure to achieve cost savings and improve sustainability, without compromising on all-important product safety. The latest thermoform packaging technology can provide a transformative solution to these concerns, and lead to savings at all stages of the packaging process.

The medical and pharma industries require fully reliable packaging that offers the maximum possible protection for products designed to care for and preserve the health of people. Consequently, companies in these industries require packaging solutions that meet the strictest regulations required by these sectors.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
About the author

Alastair Cook is a Product Manager at ULMA Packaging UK. He has worked for the company since its formation 18 years ago, and has been integral to the technical development of a host of ULMA packaging machinery during this time. Alastair is an expert in the packaging industry and has utilised his broad knowledge in the development of ULMA’s range of vertical and horizontal packaging machines for produce resealable packs. He specialises in the fields of thermoforming and tray sealers and has taken an active role in the development of recyclable material options for ULMA’s thermoforming range.
Print this page
Send to a friend
Privacy statement
News and Press Releases

Avantor® Opens Single-Use Logistics Hub to Strengthen Global Biopharma Supply Chain

New facility in Westminster, Mass., provides reliable and comprehensive support for single-use business.
More info >>

White Papers

Device Develop for Combo Products


Combination products are defined as therapeutics combining two or more products (drug/device, biologics/device, biologics/drugs or drug/device/biologics), regulated and sold as a single unit. As these pharmaceutical and biological therapies and treatments have evolved, so has the need to develop appropriate delivery mechanisms for these applications. When developing a combination product, there are many things that need to be considered – the critical relationships between device development and the pharmaceutical or biologic, early establishment of regulatory and clinical strategies, understanding ‘user’ needs, determining product requirements, as well as, device manufacturing variation.
More info >>




©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement